Policy & Equity
Government Launches Healthcare Fraud Crackdowns, Raising New Privacy Concerns
New federal anti-fraud efforts are creating a cross-agency monitoring system, raising new concerns about patient privacy.
6/23/2026
Afy Okoye is a San Francisco-based columnist at Health Stack, where she covers AI, policy, and innovation. With over eight years of experience managing global drug launches for leading pharmaceutical brands and developing value-based payment strategies, she brings a practical perspective on how innovation and policy shapes payers, clinicians, and corporations. She currently leads marketing for one of the first companies using generative AI to pioneer de novo drug design and engineer novel therapeutics from scratch.
Afy holds a M.S. in International Health Policy and Economics from the London School of Economics and dual B.A. degrees in Journalism and Political Science from Georgia State University. A lifelong learner, she spends her free time uncovering hidden stories, writing creative prose, and adventuring with her spunky schnauzer. You can connect with her on LinkedIn or Instagram (@okafy).New federal anti-fraud efforts are creating a cross-agency monitoring system, raising new concerns about patient privacy.
Competition in the obesity treatment market grows as Eli Lilly’s retatrutide moves closer to FDA submission.
The technology aims to improve consistency in embryo selection decisions, while offering support to professionals
Lawsuits in Georgia, Alabama and Mississippi challenge rules that bar direct-entry midwives.
The U.S. Food and Drug Administration made a significant step in the use of predictive algorithms for sepsis detection care. The FDA cleared the first AI-based early-warning system designed to detect sepsis in hospitalized patients. The John Hopkins University developed the Targeted Real-Time Early Warning System to use real-time patient data from electronic health records […]
Federal regulators are seeking to reposition psilocybin and other psychedelic treatments from fringe to clinical practice.
Recent studies revealed potential safety risks in ChatGPT Health, leading to growing concern for AI.
A new genetic study is clarifying why all patients don’t lose weight while using GLP-1s.
The technology company’s recent health integration update highlights the evolution of AI in the healthcare industry
Federal leadership for the nation’s top health agencies is changing as the administration shifts focus.
As enhanced Affordable Care Act subsidies disappear, major insurers are retreating from the marketplace
Utah’s historic launch of the first AI doctor authorized to prescribe medication has triggered fierce backlash from the state’s medical board. In a letter sent to the Utah Department of Commerce, the Utah Medical Licensing Board called for immediate suspension of the pilot program. The board requested further investigation into the safety and implementation of […]